Global Custom Market Research Reports Provider Company

phone

Aevi Genomic Medicine Inc (GNMX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The companys pipeline products include AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glutamatergic neuromodulator, which is in Phase II/III SAGA trial for adolescent attention deficit hyperactivity disorder patients with specific mutations in their metabotropic glutamate receptor gene network. Aevis product candidate AEVI-002, is an anti-light monoclonal antibody that is in Phase I clinical trial for use in severe pediatric onset crohns disease. It collaborates with other research institutes and companies. Aevi is headquartered in Wayne, Pennsylvania, the US.

Aevi Genomic Medicine Inc Key Recent Developments

Nov 02,2017: Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results
Aug 09,2017: Aevi Genomic Medicine Reports Second Quarter 2017 Financial Results
May 10,2017: Aevi Genomic Medicine Announces First Quarter 2017 Operating Results
May 10,2017: Aevi Genomic Medicine Q1 net loss decreases
Mar 09,2017: Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

This comprehensive SWOT profile of Aevi Genomic Medicine Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aevi Genomic Medicine Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Aevi Genomic Medicine Inc - Key Information

Aevi Genomic Medicine Inc - Overview

Aevi Genomic Medicine Inc - Key Employees

Aevi Genomic Medicine Inc - Key Employee Biographies

Aevi Genomic Medicine Inc - Key Operational Heads

Aevi Genomic Medicine Inc - Major Products and Services

Aevi Genomic Medicine Inc - History

Aevi Genomic Medicine Inc - Company Statement

Aevi Genomic Medicine Inc - Locations And Subsidiaries

Aevi Genomic Medicine Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Aevi Genomic Medicine Inc - Business Description

Aevi Genomic Medicine Inc - Corporate Strategy

Aevi Genomic Medicine Inc - SWOT Analysis

SWOT Analysis - Overview

Aevi Genomic Medicine Inc - Strengths

Aevi Genomic Medicine Inc - Weaknesses

Aevi Genomic Medicine Inc - Opportunities

Aevi Genomic Medicine Inc - Threats

Aevi Genomic Medicine Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Aevi Genomic Medicine Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Aevi Genomic Medicine Inc, Key Information

Aevi Genomic Medicine Inc, Key Ratios

Aevi Genomic Medicine Inc, Share Data

Aevi Genomic Medicine Inc, Major Products and Services

Aevi Genomic Medicine Inc, History

Aevi Genomic Medicine Inc, Key Employees

Aevi Genomic Medicine Inc, Key Employee Biographies

Aevi Genomic Medicine Inc, Key Operational Heads

Aevi Genomic Medicine Inc, Other Locations

Aevi Genomic Medicine Inc, Subsidiaries

Aevi Genomic Medicine Inc, Key Manufacturing facilities

Aevi Genomic Medicine Inc, Key Competitors

Aevi Genomic Medicine Inc, SWOT Analysis

Aevi Genomic Medicine Inc, Ratios based on current share price

Aevi Genomic Medicine Inc, Annual Ratios

Aevi Genomic Medicine Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Aevi Genomic Medicine Inc, Performance Chart

Aevi Genomic Medicine Inc, Ratio Charts

Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The companys pipeline products include

View Report

Aevis Victoria SA (Aevis Victoria), a subsidiary of Medical Research, Services & Investments SA, is a diversified company that invests in healthcare, hospitality, telemedicine, life sciences and lifestyle. It owns

View Report

AEVIS Holding SA (AEVS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports